Enzo Biochem

These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.
Company Growth (employees)
Type
Public
HQ
New York, US
Founded
1976
Size (employees)
433 (est)-2%
Website
enzo.com
Enzo Biochem was founded in 1976 and is headquartered in New York, US

Enzo Biochem Office Locations

Enzo Biochem has an office in New York
New York, US (HQ)
527 Madison Ave

Enzo Biochem Financials and Metrics

Enzo Biochem Financials

Enzo Biochem's revenue was reported to be $102.8 m in FY, 2016
USD

Revenue (Q3, 2017)

27.1 m

Net income (Q3, 2017)

(71 k)

EBIT (Q3, 2017)

(227 k)

Market capitalization (13-Dec-2017)

412.8 m

Cash (30-Apr-2017)

62.6 m
Enzo Biochem's current market capitalization is $412.8 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

93.7 m95.9 m97.6 m102.8 m

Revenue growth, %

2%2%5%

R&D expense

3.5 m

Operating expense total

3.5 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

24.1 m22.9 m24 m24.8 m23.1 m24 m25.2 m24.6 m26.4 m26.3 m26.3 m27.1 m

R&D expense

817 k832 k849 k791 k834 k809 k867 k861 k882 k822 k483 k766 k

General and administrative expense

11.2 m10.5 m

Operating expense total

27.2 m26.5 m24.5 m27.9 m27 m26.8 m20.5 m17.1 m28.9 m822 k11.6 m11.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

9 m17.5 m18.1 m67.8 m

Accounts Receivable

12.3 m12.5 m6.7 m6.7 m

Inventories

8.8 m8.7 m7.4 m7 m

Current Assets

32.6 m40.7 m46.5 m91.4 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

7.4 m7.6 m14.8 m16.6 m15.3 m14.4 m30.6 m37 m32.4 m67.2 m62.4 m62.6 m

Accounts Receivable

6.7 m6.7 m

Inventories

9.1 m9.2 m9 m8.5 m8.3 m8 m7.6 m7.4 m7 m7.2 m7.1 m7.2 m

Current Assets

32.4 m30.6 m38.2 m39.7 m37 m36.1 m52.8 m59.2 m55.2 m90.4 m86.9 m87.5 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(18.2 m)(10 m)(2.3 m)45.3 m

Accounts Receivable

(2.6 m)(3.2 m)(2 m)(4.8 m)

Inventories

60 k159 k1.2 m466 k

Cash From Operating Activities

(10 m)(1.7 m)(3.7 m)53.1 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(2.8 m)(6.4 m)(6.8 m)(3.7 m)(7.8 m)(10.7 m)4.4 m11.3 m9.2 m(1.5 m)(2.5 m)(2.6 m)

Accounts Receivable

(2.3 m)(1.3 m)(2.5 m)(482 k)(524 k)(940 k)(1.4 m)(2 m)(3 m)(150 k)(2.2 m)(3.2 m)

Inventories

(252 k)(381 k)(144 k)107 k306 k597 k(210 k)(20 k)447 k(298 k)(238 k)(213 k)

Cash From Operating Activities

(3.3 m)(4.7 m)(2.7 m)(2.8 m)(6.5 m)(8.2 m)13.2 m20.1 m17 m(333 k)(2.8 m)(1.9 m)
Y, 2017

Financial Leverage

1.2 x
Show all financial metrics

Enzo Biochem Operating Metrics

FY, 2016

Patents Issued

314

Patents Pending

146

Facilities

2
Show all operating metrics

Enzo Biochem Market Value History

Enzo Biochem Revenue Breakdown

Enzo Biochem's Web-traffic and Trends

Enzo Biochem Company Life and Culture

You may also be interested in